CVS Health reported strong second-quarter results that exceeded Wall Street expectations across all three of its business segments, prompting the company to increase its full-year financial guidance on Wednesday. The healthcare company now projects adjusted profit between $7.90 and $8.10 per share for 2026, up from prior guidance of $7.30 to $7.50 per share. Revenue expectations were also raised to at least $414 billion from the previous outlook of at least $405 billion.
Despite the robust earnings report, CVS shares declined more than 6% in morning trading. The decline appeared tied to management commentary regarding anticipated membership declines in Caremark, the company’s pharmacy benefit manager unit. CVS characterized its outlook for the remainder of the year as cautious, citing elevated medical costs and potential macroeconomic headwinds.
The company’s insurance unit, Aetna, demonstrated particular strength with a medical benefit ratio of 87.4%, improving from 89.9% in the prior year and beating analyst expectations of 89.8%. Insurance segment revenue reached $37.54 billion, exceeding analyst estimates of $35.66 billion. The improvement reflected strength in government plans and the absence of a premium deficiency reserve that had been recorded in the prior-year period. Medical membership in the insurance unit stood at 26 million as of June 30, essentially flat compared with March 31.
The pharmacy and consumer wellness division generated $33.82 billion in quarterly sales, surpassing estimates of $33.16 billion, while the health services segment produced $51.8 billion in revenue, substantially exceeding the $47.78 billion forecast. CVS attributed improvements partly to its ongoing turnaround plan, which has involved $2 billion in cost reductions, store closures, leadership changes, and cost management within Medicare Advantage plans. Additionally, CVS announced a collaboration with Eli Lilly to provide obesity treatments Zepbound and Foundayo through the CVS Health app beginning in the fourth quarter.
Article Attribution | Read More at Article Source
Article summary produced by Claude AI